SCHEMBL31683136

SCHEMBL31683136

CC(C)(C)OC(=O)N(CCO[Si](C)(C)C(C)(C)C)Cc1ccc2cc(C(=O)O)oc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER2 P43116 2/20 0.42
TBXAS1 P24557 1/20 0.39
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
HDAC1 Q13547 2/20 0.36
HDAC3 O15379 1/20 0.36
HDAC2 Q92769 1/20 0.36
NCOR2 Q9Y618 1/20 0.36
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
PIM1 P11309 3/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
CSNK2A1 P68400 1/20 0.33
CSNK2A3 Q8NEV1 1/20 0.33
SSTR4 P31391 1/20 0.32
GRM2 Q14416 1/20 0.32
CYP2D6 P10635 1/20 0.32
BACE1 P56817 1/20 0.32
ADRB3 P13945 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31683110 0.89 HSD17B10 (0.36) PTGER2LMNAHDAC1HDAC3HDAC2
SCHEMBL31683224 0.87 HDAC6 (0.36) PTGER2HDAC1HDAC3HDAC2NCOR2
SCHEMBL31683119 0.87 HDAC1 (0.33) PTGER2HDAC1HDAC3HDAC2NCOR2
SCHEMBL31683102 0.86 ALDH1A1 (0.42) LMNATP53MEN1KMT2AALDH1A1
SCHEMBL31683129 0.83 GRM2 (0.36) HDAC1HDAC3HDAC2NCOR2SSTR4
SCHEMBL31683074 0.81 BACE1 (0.32) LMNAHDAC1HDAC3HDAC2NCOR2
SCHEMBL14185973 0.80 HDAC3 (0.47) LMNAHDAC1HDAC3HDAC2NCOR2
SCHEMBL16794210 0.78 SSTR4 (0.42) LMNAHDAC1HDAC3HDAC2NCOR2
SCHEMBL849068 0.78 SSTR4 (0.41) HDAC1HDAC3HDAC2NCOR2MEN1
SCHEMBL31683071 0.74 HDAC1 (0.42) PTGER2LMNAHDAC1HDAC3HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250282742-A1 BENZOFURAN DERIVATIVES FOR TARGETING AUTOPHAGY Automera PTE. LTD (SG) 2025-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250282742-A1 BENZOFURAN DERIVATIVES FOR TARGETING AUTOPHAGY SQSTM1, BECN1, TFEB PTGER2 4026/4885TBXAS1 922/4885LMNA 764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.